Question

consider this claim: prescription drugs should not be advertised directly to consumers because of the potential risk of misinforming the public. which is the strongest evidence to support the claim? a survey investigating the consumer impact of advertisements for prescription drugs found that one - third of respondents have asked their doctors for more information about a drug they learned about from an ad. according to a study published in a medical journal, fifty - five percent of the claims made in drug ads to consumers were considered \potentially misleading\ and two percent were \false.\ researchers at dartmouth college analyzed pharmaceutical spending trends over a twenty - year span and found that spending on consumer direct - to - consumer advertisements increased from $2.1 billion in 1997 to $9.6 billion in 2016.

Explanation:

The claim is that prescription - drug direct - to - consumer advertising should be banned due to misinformation risk. The study showing that 55% of drug ad claims to consumers were potentially misleading and 2% were false directly supports the misinformation risk. The first option just shows consumers asking for more info, not misinformation. The third option is about spending trends, not misinformation.

Answer:

According to a study published in a medical journal, fifty - five percent of the claims made in drug ads to consumers were considered "potentially misleading" and two percent were "false."